Home › Allergy › Massachusetts › Boston
Allergy clinical trials in Boston, MA
6 studies for Allergy are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
RecruitingPhase 2
- Massachusetts General Hospital, Boston
Study of Oral Food Challenge Biomarkers (SAFER)
RecruitingObservational study
- Boston Children's Hospital: Allergy and Asthma Program, Boston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
Registry of Asthma Characterization and Recruitment 3 (RACR3)
RecruitingObservational studyHealthy volunteers welcome
- Boston Children's Hospital: Department of Immunology, Boston
LYmph Node eXamination in Cat Allergen Immunotherapy
RecruitingEarly phase 1
- Brigham and Women's Hospital: Division of Allergy and Clinical Immunology, Boston
Omalizumab Weight-Based Dosing Efficacy Trial
RecruitingPhase 2
- Massachusetts General Hospital, Boston
About Allergy
An allergy is a reaction by your immune system. Substances that cause reactions include pollen and food. Find the full list of allergies and symptoms.
More about Allergy on MedlinePlus
Allergy trials in other cities
- New York City, NY6 studies
- Mountain View, CA5 studies
- Nashville, TN5 studies
- Washington, DC4 studies
- Ann Arbor, MI4 studies
- Cincinnati, OH3 studies
- Chicago, IL3 studies
- Durham, NC3 studies
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.